Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Natàlia Vilor‐Tejedor, Alyssa Stevensson et al.|JAMA Neurology|2021Cited by 627
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PETCécile Tissot, Pedro Rosa‐Neto, Joseph Therriault et al.|EBioMedicine|2022Cited by 76
Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s diseaseJaime Fernández Arias, Pedro Rosa‐Neto, Joseph Therriault et al.|Brain Communications|2023Cited by 16
Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Pedro Rosa‐Neto, Tharick A. Pascoal et al.|European Journal of Nuclear Medicine and Molecular Imaging|2025Cited by 3
Adapting to reality: Effect of Online Assessments as Compared to In‐Person AssessmentsVanessa Pallen, Pedro Rosa‐Neto, Nesrine Rahmouni et al.|Alzheimer s & Dementia|2022Cited by 1